Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law

e-Competitions Bulletin, No. 88026, Nov. 2018

10 Pages Posted: 11 Nov 2018

Date Written: October 18, 2018

Abstract

In this overview, I summarize pharmaceutical antitrust law in the US and EU on settlements, product hopping, sample denials, citizen petitions, and rebates/bundling.

Keywords: Pharmaceutical, Antitrust, Settlements, Product Hopping, Sample Denials, Citizen Petitions, Rebates/Bundling

JEL Classification: I18, K21, L40, L41, L43, L65, O34, O38

Suggested Citation

Carrier, Michael A., Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law (October 18, 2018). e-Competitions Bulletin, No. 88026, Nov. 2018. Available at SSRN: https://ssrn.com/abstract=3269506

Michael A. Carrier (Contact Author)

Rutgers Law School ( email )

217 North Fifth Street
Camden, NJ 08102-1203
United States
856-225-6380 (Phone)
856-225-6516 (Fax)

Register to save articles to
your library

Register

Paper statistics

Downloads
146
rank
190,894
Abstract Views
477
PlumX Metrics